Procter & Gamble Health Ltd Share Price
(PGHL)
₹5434.05▲0.38%
as on 04:01PM, 07 Feb 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 7.3 % |
3 Month Return | -2.44 % |
1 Year Return | -1.66 % |
Market Stats | |
Previous Close | ₹5,413.40 |
Open | ₹5,397.00 |
Volume | 4,972.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹8,985.91Cr |
P/E Ratio
0PEG Ratio
0Market Cap
₹8,985.91 Cr
P/B Ratio
15.57
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
31.18
Excluding Excise Duty and Other Income, represents Net Revenue
Procter & Gamble Health Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Procter & Gamble Health Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Procter & Gamble Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, PGHL stock has moved up by 7.3%
MF Holding Up
Mutual Funds have increased holdings from 10.45% to 10.64% in Dec 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 6.61% to 7.01% in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.82% of holdings in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.6% return, outperforming this stock by 142.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 66.7% return, outperforming this stock by 68.3%
Retail Holding Down
Retail Investor have decreased holdings from 26.74% to 26.46% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 51.82% | 0.00 | |
Foreign Institutions | 7.01% | 6.17 | |
Mutual Funds | 10.64% | 1.79 | |
Retail Investors | 26.46% | ||
Others | 4.07% |
Procter & Gamble Health Ltd’s net profit jumped 25.56% since last year same period to ₹82.33Cr in the Q2 2024-2025. On a quarterly growth basis, Procter & Gamble Health Ltd has generated 390.64% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2024, Procter & Gamble Health Ltd has declared dividend of ₹60 - translating a dividend yield of 5.70%.
Read More about DividendsBearish
Neutral
Bullish
Procter & Gamble Health Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹8,985.91 Cr | 5.19% | 0.53 | NA | NA | |
BUY | ₹29,673.36 Cr | 117.38% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹16,786.24 Cr | 22.36% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹5,174.50 Cr | -4.05% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹13,997.88 Cr | 41.48% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Procter & Gamble Health Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Procter & Gamble Health Ltd share price today stands at ₹5434.05, Open: ₹5397, Previous Close: ₹5413.4, High: ₹5455, Low: ₹5326.65, 52 Week High: ₹5850, 52 Week Low: ₹4636.55.
Procter & Gamble Health Ltd is listed on NSE
Procter & Gamble Health Ltd is listed on BSE
Today's traded volume of Procter & Gamble Health Ltd(PGHL) is 4,972.00.
Today's market capitalisation of Procter & Gamble Health Ltd(PGHL) is ₹8985.91Cr.
Procter & Gamble Health Ltd (PGHL) share price is ₹5434.05. It is down -7.11% from its 52 Week High price of ₹5850
Procter & Gamble Health Ltd (PGHL) share price is ₹5434.05. It is up 17.20% from its 52 Week Low price of ₹4636.55